Fig. 2From: Prevalence, one-year-incidence and predictors of carcinoid heart diseaseROC analyses of hydroxyindoleacetic acid (5-HIAA) to discriminate patients with neuroendocrine tumours (NET) without carcinoid heart disease (CHD) and NET patients with CHD manifestation (green line, 5-HIAA; red line, reference line), AUC, area under the curve; CI, confidence intervalBack to article page